Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Routine hepatitis B immunisation in India: cost-effectiveness assessment.

M A Miller1, M Kane

  • 1Research Fogarty International Center NIH, Bethesda, MD 20892-2220, USA. millermark@who.ch

Indian Journal of Pediatrics
|July 6, 2000
PubMed
Summary

Hepatitis B immunization is a highly cost-effective public health investment for India. It saves life years at a cost well below the national gross domestic product, making it a top health priority.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

3-methylindole induces transient olfactory mucosal injury in ponies.

Veterinary pathology·2003
Same author

Immunohistochemical characterization of canine intestinal epithelial and mesenchymal tumours with a monoclonal antibody to hepatocyte paraffin 1 (Hep Par 1).

The Histochemical journal·2003
Same author

Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors.

Veterinary pathology·2003
Same author

Patient-focused care and its implications for nutrition practice.

Journal of the American Dietetic Association·2003
Same author

The influence of surface roughness on stem-cement gaps.

The Journal of bone and joint surgery. British volume·2002
Same author

Reducing cholesterol and atherosclerosis: the importance of cellular adhesion molecules?

QJM : monthly journal of the Association of Physicians·2002

Area of Science:

  • Public Health
  • Health Economics
  • Immunization Programs

Background:

  • Hepatitis B poses a significant public health burden globally and in India.
  • Assessing the economic viability of public health interventions is crucial for resource allocation.

Purpose of the Study:

  • To evaluate the cost-effectiveness of hepatitis B immunization as a public health intervention in India.
  • To determine if hepatitis B vaccination aligns with World Bank guidelines for cost-effective health investments.

Main Methods:

  • Analysis based on World Bank economic guidelines for health interventions.
  • Calculation of cost per life year saved for hepatitis B immunization.

Main Results:

  • Hepatitis B immunization is projected to save life years at a cost significantly lower than India's per-capita gross domestic product.

Related Experiment Videos

  • The intervention meets established criteria for cost-effectiveness in public health.

    • Conclusions:

    • Hepatitis B immunization represents an excellent and highly cost-effective public health investment for India.
    • Implementing widespread hepatitis B vaccination is recommended as a priority health initiative.